SCHEMBL31453191

SCHEMBL31453191

CC(C)(C)OC(=O)N(C(=O)OC(C)(C)C)c1ncc([N+](=O)[O-])cc1Br

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
CYP2C19 P33261 1/20 0.39
MAPT P10636 7/20 0.37
HTT P42858 2/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
GAA P10253 3/20 0.36
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 2/20 0.33
ALOX5 P09917 1/20 0.33
CYP1A2 P05177 1/20 0.33
PDPK1 O15530 1/20 0.32
KCNH2 Q12809 1/20 0.32
SSTR4 P31391 1/20 0.32
AURKA O14965 1/20 0.32
RPS6KB1 P23443 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1163011 0.86 ALDH1A1 (0.43) ALDH1A1CYP2C19MAPTHTTGAA
SCHEMBL31453130 0.86 ALDH1A1 (0.46) ALDH1A1CYP2C19MAPTHTTGAA
SCHEMBL31453190 0.85 ALDH1A1 (0.42) ALDH1A1CYP2C19MAPTHTTGAA
SCHEMBL9909962 0.85 ALDH1A1 (0.42) ALDH1A1CYP2C19MAPTHTTGAA
SCHEMBL31453153 0.84 ALDH1A1 (0.41) ALDH1A1CYP2C19MAPTHTTGAA
SCHEMBL31453237 0.81 ALDH1A1 (0.40) ALDH1A1CYP2C19MAPTHTTGAA
SCHEMBL29126475 0.81 ALDH1A1 (0.44) ALDH1A1CYP2C19MAPTHTTCRHBP
SCHEMBL31453189 0.81 ALDH1A1 (0.39) ALDH1A1CYP2C19MAPTHTTGAA
SCHEMBL26310184 0.80 AAK1 (0.37) ALDH1A1CYP2C19MAPTHTTGAA
SCHEMBL25522858 0.78 CYP2C19 (0.44) ALDH1A1CYP2C19MAPTHTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025051157-A1 PYRIDINE-2(1H)-KETONE PRMT5-MTA INHIBITOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF 赛诺哈勃药业(成都)有限公司 2025-03-13 WO disclosed